About NeuroOne

Pioneer in Thin Film, High Resolution

Printed Circuit Electrode Technology

Executing On Our Plan For Growth

NeuroOne is a medical technology company focused on revolutionizing the standard of care for patients suffering from conditions such as epilepsy, Parkinson’s disease, dystonia, essential tremors, and other related brain disorders. We believe our thin film electrodes will be able to be placed with minimally invasive procedures and improve the outcomes for patients with neurological disorders. Additionally, we believe that the higher resolution provided by our electrodes can enable the usage of powerful computing techniques such as machine learning and artificial intelligence.

2017 was a transformational year for us. We completed a reverse merger, up-listed to the OTCQB and raised over $1.8 million in private transactions. Strategically, we established a physician advisory board, completed an early feasibility study for our depth electrode and combination diagnostic/ablation depth electrode1, and filed two provisional patents with the USPTO.

In 2018, we recruited thought leaders and highly renowned AI neurosurgeons to establish our Artificial Intelligence Advisory board. We also established our headquarters, conducted multiple rounds of pre-clinical testing on our ablation electrode at Cleveland Clinic2 and a pre-clinical feasibility study for minimally invasive placement of our cortical electrodes at Mayo Clinic3.

For 2019, we expect to debut our cortical electrodes, pending FDA 510(k) clearance. We submitted a 510(k) filing to the FDA for our cortical electrode product line and plan to submit our depth electrode product line later this year. Upon clearance, we intend to launch our electrode products to targeted industry leading, medical centers. We also plan on exploring additional product applications with insight from our AI advisory board.

Positioned
for the Long Term

We built an experienced leadership team to prepare for the commercialization of our products and grow our network of thought leaders. We are focused on continuing to expand our product portfolio and helping shape one of the most exciting frontiers in healthcare.

References

  1. Data on file
  2. Data on file
  3. Data on file